General Information of DTT (ID: TT0PZR5)

DTT Name Leukotriene CysLT2 receptor (CYSLTR2) DTT Info
Gene Name CYSLTR2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BAY-X-7195 DM2XE80 Asthma CA23 Phase 2 [1]
------------------------------------------------------------------------------------
7 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AS-35 DMC2WI7 Asthma CA23 Discontinued in Phase 2 [2]
DS-4574 DM8GZWC Asthma CA23 Discontinued in Phase 2 [3]
Sulukast DMBSLZV Asthma CA23 Discontinued in Phase 2 [4]
FPL-55712 DMF1CDK Asthma CA23 Terminated [5]
ICI-198615 DM0195G Asthma CA23 Terminated [6]
LY-290154 DMPZ7AO Asthma CA23 Terminated [7]
MDL-43291 DMBIDQX Asthma CA23 Terminated [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Discontinued Drug(s)
10 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BayCysLT2 DMKFTZA Discovery agent N.A. Investigative [9]
BAYu9773 DMXQ14V Discovery agent N.A. Investigative [10]
CGP-57698 DMYZ72J Discovery agent N.A. Investigative [11]
HAMI3379 DMJN0BL Discovery agent N.A. Investigative [12]
LTC4 DM702WR Discovery agent N.A. Investigative [13]
LTD4 DMIUZX3 Discovery agent N.A. Investigative [13]
LTE4 DMCPB0Q Discovery agent N.A. Investigative [14]
N-methyl LTC4 DM6XYCU Discovery agent N.A. Investigative [14]
pobilukast DMURB4Y Discovery agent N.A. Investigative [15]
[3H]LTC4 DMD09BO Discovery agent N.A. Investigative [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Investigative Drug(s)
Molecule Interaction Atlas

References

1 The effect of a novel leukotriene C4/D4 antagonist, BAY-x-7195, on experimental allergic reactions. Prostaglandins. 1995 Nov-Dec;50(5-6):269-85.
2 Inhibition of radiolabeled leukotriene-binding by AS-35 in guinea pig lung membrane fraction. Jpn J Pharmacol. 1992 Apr;58(4):357-64.
3 Inhibitory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene receptor antagonism, on gastric acid secretion in rats. Eur J Pharmacol. 1994 Apr 1;255(1-3):229-34.
4 The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig. Br J Pharmacol. 1989 Sep;98(1):259-67.
5 Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat. Br J Pharmacol. 1991 Apr;102(4):865-70.
6 Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma. Biochem Pharmacol. 1992 Oct 6;44(7):1411-5.
7 DOI: 10.1021/op060036x
8 Conformationally restricted leukotriene receptor antagonists: [(octahydro-2-oxo-7-tetradecylidene-2H-1-benzopyran-8-yl)thio]ace tic acids. Pharmacology. 1990;40(5):271-6.
9 Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor. FASEB J. 2011 Oct;25(10):3519-28.
10 BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes. Eur J Pharmacol. 1994 Nov 3;264(3):317-23.
11 A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lun... Mol Pharmacol. 2000 Jun;57(6):1182-9.
12 Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. Br J Pharmacol. 2010 May;160(2):399-409.
13 Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol. 2000 Dec;58(6):1601-8.
14 Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT agonist, N-methyl-leukotriene C in calcium reporter and beta arrestin assays. Mol Pharmacol. 2011 Feb;79(2):270-8.
15 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 270).
16 The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor. Biochem Biophys Res Commun. 2000 Aug 2;274(2):316-22.